Essential role of calcium in vascular endothelial growth factor A‐induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole

Abstract
Vascular endothelial growth factor‐α (VEGF‐A) plays a major role in tumor angiogenesis and raises the concentration of intracellular free calcium ([Ca2+]i). Carboxyamidotriazole (CAI), an inhibitor of calcium influx and of angiogenesis, is under investigation as a tumoristatic agent. We studied the effect of CAI and the role of [Ca2+]i in VEGF‐α signaling in human endothelial cells. VEGF‐α induced a biphasic [Ca2+]i signal. VEGF‐α increased the level of intracellular inositol 1,4,5‐trisphosphate (IP3), which suggests that VEGF‐A releases Ca2+ from IP3‐sensitive stores and induces store‐operated calcium influx. Reduction of either extracellular or intracellular free Ca2+ inhibited VEGF‐A‐induced proliferation. CAI inhibited IP3 formation, both phases of the calcium signal, nitric oxide (NO) release, and proliferation induced by VEGF‐A. CAI prevented neither activation of VEGF receptor‐2 (VEGFR‐2) (KDR/Flk‐1), phospholipase C‐γ, or mitogen‐activated protein kinase (MAP kinase) nor translocation of nuclear factor of activated T cells (NFAT). We conclude that calcium signaling is necessary for VEGF‐A‐induced proliferation. MAP kinase activation occurs independently of [Ca2+]i but is not sufficient to induce proliferation in the absence of calcium signaling. Inhibition of the VEGF‐Ainduced [Ca2+]i signal and proliferation by CAI can be explained by inhibition of IP3 formation and may contribute to the antiangiogenic action of CAI. Calcium‐dependent NO formation may represent a link between calcium signaling and proliferation.
Funding Information
  • Deutsche Forschungsgemeinschaft (SFB497/C1, SFB451/B1, WA734/5-1)
  • Merck Sharp and Dohme United Kingdom